In this podcast interview, Jason Evans (Scientist at IQVIA Laboratories) discusses the importance of automation and key advantages of taking an assay from the bench to an automated platform. He also explains the increase in throughput when his lab transitioned to automated assays and the hurdles he faced when automating assays.
Related Insights

ADME Services
Accelerating your drug discovery, preclinical and clinical programs

Automation within an ADME Laboratory
Taking an assay from bench to an automated platform

Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform
Developing Assays for Novel Drugs
Current science regarding hybrid assays, why they are considered the next "big thing," the technical challenges, and the regulatory impact of these assays.
Strategies for Effective Neutralizing Cell Based Assays in Early Immunogenicity Risk Assessment
Quantitative Assays for Peptides using LC-MS
Quantitative high-throughput analysis of peptide therapeutics and biomarkers to regulated bioanalytical standards
Hybrid Assays for Protein Bioanalysis
Combining immuno-affinity with liquid chromatography-mass spectrometry (LC-MS)

Absolute Bioavailability Analysis Using Stable Isotopes
A Liquid Chromatography-Tandem Mass Spectrometry Approach

Bioanalysis for Immuno Oncology with Mike Brown
I-O clinical development podcast series
Bioanalytical & ADME Laboratory Services
Accelerate and enhance your discovery, preclinical and clinical programs